Cross Site Scripting Vulnerability in erjinzhi 10OA from Erjinzhi
CVE-2025-10271

5.3MEDIUM

Key Information:

Vendor

Erjinzhi

Status
10oa
Vendor
CVE Published:
11 September 2025

Badges

👾 Exploit Exists🟡 Public PoC

What is CVE-2025-10271?

A cross site scripting vulnerability exists in the erjinzhi 10OA 1.0 product. This flaw affects the file located at /trial/mvc/finder. An attacker can exploit this vulnerability by manipulating the 'Name' argument, allowing for remote execution of harmful scripts. This issue has been publicly disclosed and poses a significant risk to users. Despite attempts to engage with the vendor for remediation, there has been no response.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

10OA 1.0

Exploit Proof of Concept (PoC)

PoC code is written by security researchers to demonstrate the vulnerability can be exploited. PoC code is also a key component for weaponization which could lead to ransomware.

CVE-2025-10271 - Proof of Concept

References

https://vuldb.com/?id.323641
vdb-entrytechnical-description
https://vuldb.com/?ctiid.323641
signaturepermissions-required
https://vuldb.com/?submit.643032
third-party-advisory

CVSS V4

Score:
5.3
Severity:
MEDIUM
Confidentiality:
None
Integrity:
Low
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • 🟡

    Public PoC available

  • 👾

    Exploit known to exist

  • Vulnerability published

  • Vulnerability Reserved

Credit

Zre0x1c (VulDB User)
JSON
.